Editorial: Herbal medicines for gastrointestinal and hepatic diseases - novel pharmacological and toxicological approaches, Volume I.
作者信息
Hasnat Muhammad, Baig Mirza Muhammad Faran Ashraf, Saleem Mohammad, Ullah Aftab, Nadeem Muhammad Faisal, Durazzo Alessandra, Lucarini Massimo
机构信息
Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
The Hong Kong University of Science and Technology, Hong Kong, Hong Kong SAR, China.
出版信息
Front Pharmacol. 2023 Jul 7;14:1157229. doi: 10.3389/fphar.2023.1157229. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Herbal medicines for gastrointestinal and hepatic diseases - novel pharmacological and toxicological approaches, Volume I.社论：用于胃肠和肝脏疾病的草药——新的药理学和毒理学方法，第一卷
Front Pharmacol. 2023 Jul 7;14:1157229. doi: 10.3389/fphar.2023.1157229. eCollection 2023.
2
Herbal therapies in gastrointestinal and hepatic disorders: An evidence-based clinical review.用于胃肠及肝脏疾病的草药疗法：一项基于证据的临床综述。
Front Pharmacol. 2022 Oct 5;13:962095. doi: 10.3389/fphar.2022.962095. eCollection 2022.
3
Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.系统方法和多药理学在草药药物发现中的应用：以甘草为例。
J Ethnopharmacol. 2013 Apr 19;146(3):773-93. doi: 10.1016/j.jep.2013.02.004. Epub 2013 Feb 14.
4
Using omics approaches to dissect the therapeutic effects of Chinese herbal medicines on gastrointestinal cancers.运用组学方法剖析中药对胃肠道癌症的治疗作用。
Front Pharmacol. 2022 Sep 23;13:884822. doi: 10.3389/fphar.2022.884822. eCollection 2022.
5
Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients: Current evidence.基于质谱的代谢组学在草药及其活性成分中的新应用：当前证据。
Mass Spectrom Rev. 2019 Aug;38(4-5):380-402. doi: 10.1002/mas.21589. Epub 2019 Feb 28.
6
Herbal medicines for fatty liver diseases.用于治疗脂肪肝疾病的草药
Cochrane Database Syst Rev. 2013 Aug 24(8):CD009059. doi: 10.1002/14651858.CD009059.pub2.
7
[Research advance in metabolism of effective ingredients from traditional Chinese medicines by probiotics].[益生菌对中药有效成分代谢的研究进展]
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):31-38. doi: 10.19540/j.cnki.cjcmm.20170919.012.
8
Editorial for Special Issue on Herbal Medicines and Natural Products.关于草药和天然产物特刊的社论
Medicines (Basel). 2015 Nov 16;2(4):328-330. doi: 10.3390/medicines2040328.
9
[Profiles of effects of traditional oriental herbal medicines on central nervous systems in humans--assessment of saiboku-to and saiko-ka-ryukotsu-borei-to using EEG and pharmacokinetics of herbal medicine-derived ingredients as indices].[传统东方草药对人体中枢神经系统的作用概况——以脑电图及草药衍生成分的药代动力学为指标评估柴朴汤和柴胡加龙骨牡蛎汤]
Seishin Shinkeigaku Zasshi. 1997;99(6):355-69.
10
Active phytochemicals from Chinese herbs as therapeutic agents for the heart.来自中药的活性植物化学物质作为心脏治疗剂
Cardiovasc Hematol Agents Med Chem. 2012 Sep;10(3):251-5. doi: 10.2174/187152512802651033.
本文引用的文献
1
The interplay between herbal medicines and gut microbiota in metabolic diseases.草药与肠道微生物群在代谢性疾病中的相互作用。
Front Pharmacol. 2023 Mar 24;14:1105405. doi: 10.3389/fphar.2023.1105405. eCollection 2023.
2
Herbal preparations use in prevention and treatment of gastrointestinal and hepatic disorders-Data from Vojvodina, Serbia.草药制剂在预防和治疗胃肠道和肝脏疾病中的应用-来自塞尔维亚伏伊伏丁那的数据。
Complement Ther Med. 2019 Apr;43:265-270. doi: 10.1016/j.ctim.2019.02.018. Epub 2019 Feb 27.
3
The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome.细菌、病毒和寄生虫在肠易激综合征的起始和恶化中的可能作用。
J Cell Physiol. 2019 Jun;234(6):8550-8569. doi: 10.1002/jcp.27828. Epub 2018 Nov 27.
4
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
5
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
6
Epidemiology of viral hepatitis and HIV co-infection.病毒性肝炎与艾滋病毒合并感染的流行病学
J Hepatol. 2006;44(1 Suppl):S6-9. doi: 10.1016/j.jhep.2005.11.004. Epub 2005 Nov 21.
Zotero 插件